SELVAS Healthcare, Inc. (KOSDAQ:208370)
South Korea
· Delayed Price · Currency is KRW 4,360.00
+35.00 (0.81%)
At close: Mar 26, 2025, 3:30 PM KST
SELVAS Healthcare Revenue
In the year 2024, SELVAS Healthcare had annual revenue of 31.70B KRW with 6.34% growth. SELVAS Healthcare had revenue of 9.16B in the quarter ending December 31, 2024, with 36.10% growth.
Revenue
31.70B
Revenue Growth
+6.34%
P/S Ratio
3.38
Revenue / Employee
268.66M
Employees
118
Market Cap
107.50B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 31.70B | 1.89B | 6.34% |
| Dec 31, 2023 | 29.81B | 2.13B | 7.68% |
| Dec 31, 2022 | 27.69B | -1.40B | -4.82% |
| Dec 31, 2021 | 29.09B | 7.94B | 37.52% |
| Dec 31, 2020 | 21.15B | -1.20B | -5.36% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 300.87T |
| SK hynix | 66.19T |
| LG Energy Solution | 25.62T |
| Samsung Biologics | 4,547.32B |
| Hyundai Motor Company | 175.23T |
| Kia Corporation | 107.45T |
| Celltrion | 3,557.30B |
| KB Financial Group | 15.01T |